| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | CACNA1A ATP13A4 SLC16A13 ATP8B4 SLC39A2 SLC6A17 PIEZO1 SLC10A4 TMEM175 SLC35A1 SLC19A2 SLC44A2 ABCB6 HTR3C SLC13A3 ATP9B PKD1L3 SLC7A11 SLC7A14 ATP8B2 CHRNA3 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 CD36 SLC22A5 SLC35A2 SCN5A ATP11C SLC38A11 TMEM41B ABCC2 SLC2A12 TAP1 DISP1 | 3.74e-12 | 1289 | 180 | 40 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A ATP13A4 SLC16A13 SLC39A2 SLC6A17 PIEZO1 SLC10A4 TMEM175 SLC35A1 SLC19A2 SLC44A2 ABCB6 HTR3C SLC13A3 PKD1L3 SLC7A11 SLC7A14 CHRNA3 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 CD36 SLC22A5 SLC35A2 SCN5A SLC38A11 ABCC2 SLC2A12 TAP1 DISP1 | 3.64e-10 | 1180 | 180 | 35 | GO:0022857 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R2 FCRL2 XCR1 FLT1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 HTR3C OR2T10 TLR6 TAS2R38 PKD1L3 PTGFR S1PR3 CHRNA3 CRHR1 CRHR2 KLRK1 OR52I1 FCGR1BP PROKR2 OR10H2 OR10H1 TREM1 OR56A3 KDR OR7A17 PTGDR2 EPHA10 IL6ST CNR2 GABBR1 | 3.64e-09 | 1353 | 180 | 36 | GO:0004888 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC16A13 SLC6A17 SLC10A4 SLC35A1 SLC44A2 SLC13A3 SLC7A11 SLC25A3 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 SLC2A12 | 1.20e-08 | 296 | 180 | 16 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP13A4 SLC16A13 SLC6A17 SLC10A4 SLC35A1 SLC44A2 ABCB6 SLC13A3 SLC7A11 SLC25A3 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 ABCC2 SLC2A12 TAP1 | 1.27e-08 | 477 | 180 | 20 | GO:0022804 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R2 XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 TAS2R38 PTGFR S1PR3 CRHR1 CRHR2 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 GABBR1 | 1.43e-06 | 884 | 180 | 24 | GO:0004930 |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 2.99e-06 | 12 | 180 | 4 | GO:0050815 | |
| GeneOntologyMolecularFunction | symporter activity | SLC16A13 SLC6A17 SLC10A4 SLC13A3 SLC25A3 SLC12A4 SLC13A1 SLC22A5 SLC2A12 | 8.97e-06 | 150 | 180 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.68e-05 | 172 | 180 | 9 | GO:0044325 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC16A13 SLC10A4 SLC35A1 SLC19A2 SLC13A3 SLC7A11 SLC7A14 SLC35A3 CD36 SLC38A11 ABCC2 | 7.41e-05 | 293 | 180 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | prostaglandin F receptor activity | 8.08e-05 | 2 | 180 | 2 | GO:0004958 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 9.45e-05 | 51 | 180 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.10e-04 | 28 | 180 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A ATP13A4 SLC39A2 PIEZO1 SLC10A4 TMEM175 HTR3C SLC13A3 PKD1L3 CHRNA3 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 SCN5A | 1.11e-04 | 664 | 180 | 17 | GO:0008324 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC16A13 SLC10A4 SLC19A2 SLC13A3 SLC7A11 SLC7A14 CD36 SLC38A11 ABCC2 | 1.13e-04 | 207 | 180 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 1.13e-04 | 11 | 180 | 3 | GO:0015165 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC16A13 SLC10A4 SLC19A2 SLC13A3 SLC7A11 SLC7A14 CD36 SLC38A11 ABCC2 | 1.17e-04 | 208 | 180 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.49e-04 | 12 | 180 | 3 | GO:0001851 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.13e-04 | 33 | 180 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 2.23e-04 | 61 | 180 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | UDP-galactose transmembrane transporter activity | 2.41e-04 | 3 | 180 | 2 | GO:0005459 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor activity | 2.41e-04 | 3 | 180 | 2 | GO:0043404 | |
| GeneOntologyMolecularFunction | protein kinase C inhibitor activity | 2.41e-04 | 3 | 180 | 2 | GO:0008426 | |
| GeneOntologyMolecularFunction | corticotrophin-releasing factor receptor activity | 2.41e-04 | 3 | 180 | 2 | GO:0015056 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 2.44e-04 | 14 | 180 | 3 | GO:0005338 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.59e-04 | 138 | 180 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | RNA polymerase I core binding | 4.79e-04 | 4 | 180 | 2 | GO:0001042 | |
| GeneOntologyMolecularFunction | very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity | 4.79e-04 | 4 | 180 | 2 | GO:0102158 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A ATP13A4 SLC39A2 PIEZO1 SLC10A4 TMEM175 HTR3C SLC13A3 PKD1L3 CHRNA3 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 SCN5A | 8.56e-04 | 793 | 180 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A ATP13A4 SLC39A2 SLC10A4 TMEM175 SLC13A3 PKD1L3 ITPR1 SLC8A1 SLC12A4 SLC13A1 SCN5A | 1.08e-03 | 465 | 180 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | glycerophosphodiester phosphodiesterase activity | 1.18e-03 | 6 | 180 | 2 | GO:0008889 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.43e-03 | 25 | 180 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 1.65e-03 | 7 | 180 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | molecular sequestering activity | 1.98e-03 | 59 | 180 | 4 | GO:0140313 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.04e-03 | 196 | 180 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.12e-03 | 100 | 180 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydratase activity | 2.18e-03 | 8 | 180 | 2 | GO:0018812 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 2.18e-03 | 8 | 180 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.22e-03 | 29 | 180 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.79e-03 | 9 | 180 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 2.79e-03 | 9 | 180 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.94e-03 | 156 | 180 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | complement binding | 2.95e-03 | 32 | 180 | 3 | GO:0001848 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 PIEZO1 SLC10A4 TMEM175 ABCB6 HTR3C SLC13A3 PKD1L3 TRDN YWHAH ATP8B2 OPA1 CHRNA3 CRHR1 CRHR2 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 MTOR ATP6AP2 SLC22A5 SCN5A SLN ATP11C SLC38A11 YWHAQ ABCC2 | 9.73e-09 | 1374 | 181 | 35 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 PIEZO1 TMEM175 ABCB6 HTR3C SLC13A3 PKD1L3 TRDN YWHAH ATP8B2 OPA1 CHRNA3 CRHR1 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 MTOR ATP6AP2 SCN5A SLN ATP11C YWHAQ ABCC2 | 1.07e-08 | 1115 | 181 | 31 | GO:0034220 |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A SLC16A13 DRD2 AVPR1A CES1 SLC6A17 SLC10A4 SLC35A1 SLC19A2 SLC13A3 SLC7A11 SLC7A14 SLC35A3 CD36 SLC35A2 SLC38A11 ABCC2 MAP2K6 GABBR1 | 1.48e-07 | 515 | 181 | 19 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 PIEZO1 SLC10A4 TMEM175 ABCB6 SLC13A3 PKD1L3 TRDN YWHAH OPA1 CRHR1 CRHR2 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 ATP6AP2 SLC22A5 SCN5A SLN SLC38A11 ABCC2 | 3.07e-07 | 1157 | 181 | 29 | GO:0006812 |
| GeneOntologyBiologicalProcess | organic cation transport | CACNA1A SLC6A17 SLC19A2 SLC44A2 CHRNA3 CRHR1 CRHR2 SLC44A5 SLC22A5 GABBR1 | 6.26e-07 | 145 | 181 | 10 | GO:0015695 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A SLC16A13 DRD2 AVPR1A CES1 SLC6A17 SLC10A4 SLC19A2 SLC13A3 SLC7A11 SLC7A14 CD36 SLC38A11 ABCC2 MAP2K6 GABBR1 | 7.16e-07 | 410 | 181 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A SLC16A13 DRD2 AVPR1A CES1 SLC6A17 SLC10A4 SLC19A2 SLC13A3 SLC7A11 SLC7A14 CD36 SLC38A11 ABCC2 MAP2K6 GABBR1 | 7.64e-07 | 412 | 181 | 16 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 PIEZO1 TMEM175 ABCB6 SLC13A3 PKD1L3 TRDN YWHAH OPA1 CRHR1 CALHM4 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 ATP6AP2 SCN5A SLN ABCC2 | 7.91e-07 | 942 | 181 | 25 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 TMEM175 ABCB6 HTR3C SLC13A3 PKD1L3 TRDN YWHAH OPA1 CRHR1 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 ATP6AP2 SCN5A SLN ABCC2 | 1.88e-06 | 922 | 181 | 24 | GO:0098662 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 SLC10A4 TMEM175 ABCB6 SLC13A3 PKD1L3 TRDN YWHAH OPA1 CRHR1 CRHR2 ITPR1 SLC8A1 SLC12A4 SLC13A1 SLC22A5 SCN5A SLN SLC38A11 ABCC2 | 2.32e-06 | 1000 | 181 | 25 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A XCR1 ATP13A4 DRD2 SLC39A2 SLC6A17 TMEM175 ABCB6 HTR3C SLC13A3 PKD1L3 TRDN YWHAH OPA1 CRHR1 ITPR1 SLC25A3 SLC8A1 SLC12A4 SLC13A1 MTOR ATP6AP2 SCN5A SLN ABCC2 | 3.13e-06 | 1017 | 181 | 25 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | CACNA1A XCR1 AVPR1A SPPL3 PTGFR S1PR3 CRHR1 ITPR1 SLC8A1 CD36 KDR | 4.84e-06 | 224 | 181 | 11 | GO:0007204 |
| GeneOntologyBiologicalProcess | amine transport | 2.87e-05 | 137 | 181 | 8 | GO:0015837 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | PMP22 CACNA1A DRD2 PIEZO1 TMEM161B HTR3C TRDN YWHAH CHRNA3 SLC8A1 MTOR CD36 SCN5A KDR CNR2 GABBR1 | 3.56e-05 | 559 | 181 | 16 | GO:0042391 |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 4.46e-05 | 23 | 181 | 4 | GO:0033604 | |
| GeneOntologyBiologicalProcess | cytolysis by host of symbiont cells | 7.62e-05 | 10 | 181 | 3 | GO:0051838 | |
| GeneOntologyBiologicalProcess | negative regulation of epinephrine secretion | 7.62e-05 | 10 | 181 | 3 | GO:0032811 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | VN1R2 XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 TAS2R38 PTGFR YWHAB S1PR3 CRHR1 CRHR2 ITPR1 GPR180 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 GABBR1 | 8.76e-05 | 1395 | 181 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of epinephrine secretion | 1.04e-04 | 11 | 181 | 3 | GO:0014060 | |
| GeneOntologyBiologicalProcess | actin filament network formation | 1.04e-04 | 11 | 181 | 3 | GO:0051639 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.18e-04 | 87 | 181 | 6 | GO:0150104 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.19e-04 | 125 | 181 | 7 | GO:0051952 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.20e-04 | 55 | 181 | 5 | GO:0045332 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.26e-04 | 88 | 181 | 6 | GO:0010232 | |
| GeneOntologyBiologicalProcess | synaptic signaling | PMP22 CACNA1A APH1B DRD2 HTR5A HTR3C SLC7A11 YWHAG YWHAH CHRNA3 CRHR1 CRHR2 OPHN1 ITPR1 SLC12A4 NAPB MTOR SLITRK5 KDR CNR2 GABBR1 | 1.38e-04 | 976 | 181 | 21 | GO:0099536 |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 1.38e-04 | 12 | 181 | 3 | GO:0090481 | |
| GeneOntologyBiologicalProcess | sodium ion transport | DRD2 SLC6A17 SLC10A4 SLC13A3 YWHAH SLC8A1 SLC13A1 SLC22A5 SCN5A SLC38A11 | 1.65e-04 | 275 | 181 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | epinephrine secretion | 1.78e-04 | 13 | 181 | 3 | GO:0048242 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 1.78e-04 | 13 | 181 | 3 | GO:0015780 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.82e-04 | 60 | 181 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | PMP22 CACNA1A APH1B DRD2 HTR5A HTR3C SLC7A11 YWHAG YWHAH CHRNA3 CRHR1 CRHR2 OPHN1 SLC12A4 NAPB MTOR SLITRK5 KDR CNR2 GABBR1 | 2.05e-04 | 931 | 181 | 20 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | PMP22 CACNA1A APH1B DRD2 HTR5A HTR3C SLC7A11 YWHAG YWHAH CHRNA3 CRHR1 CRHR2 OPHN1 SLC12A4 NAPB MTOR SLITRK5 KDR CNR2 GABBR1 | 2.05e-04 | 931 | 181 | 20 | GO:0007268 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.26e-04 | 286 | 181 | 10 | GO:0007188 | |
| GeneOntologyBiologicalProcess | UDP-galactose transmembrane transport | 2.28e-04 | 3 | 181 | 2 | GO:0072334 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | PMP22 CACNA1A APH1B DRD2 HTR5A HTR3C SLC7A11 YWHAG YWHAH CHRNA3 CRHR1 CRHR2 OPHN1 SLC12A4 NAPB MTOR SLITRK5 KDR CNR2 GABBR1 | 2.29e-04 | 939 | 181 | 20 | GO:0099537 |
| GeneOntologyBiologicalProcess | circulatory system process | DRD2 AVPR1A SLC6A17 TMEM161B SLC13A3 TRDN CRHR2 VSTM4 SLC8A1 MTOR ATP6AP2 CD36 SLC22A5 SCN5A KDR ABCC2 MAP2K6 | 2.61e-04 | 733 | 181 | 17 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.66e-04 | 65 | 181 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.02e-04 | 37 | 181 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | amino acid transport | CACNA1A AVPR1A SLC6A17 SLC13A3 SLC7A11 SLC7A14 SLC38A11 GABBR1 | 3.35e-04 | 195 | 181 | 8 | GO:0006865 |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 3.35e-04 | 38 | 181 | 4 | GO:0051873 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | VN1R2 OR10H5 DRD2 OR4D1 OR2T10 TAS2R38 PKD1L3 REEP2 OR52I1 OR10H2 OR10H1 CD36 OR56A3 OR7A17 | 3.49e-04 | 547 | 181 | 14 | GO:0007606 |
| GeneOntologyBiologicalProcess | amide transport | DRD2 SLC19A2 SLC13A3 SLC7A11 FAM3D CRHR1 CRHR2 ITPR1 ZBED6 TAP1 DISP1 GABBR1 | 3.51e-04 | 420 | 181 | 12 | GO:0042886 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | TPO CACNA1A DRD2 CYP3A4 FAM3D YWHAZ CRHR1 CRHR2 ITPR1 ZBED6 ATP6AP2 UGT2B10 UGT2B15 ABCC2 DISP1 GABBR1 | 3.61e-04 | 684 | 181 | 16 | GO:0010817 |
| GeneOntologyBiologicalProcess | action potential | 4.11e-04 | 201 | 181 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | epinephrine transport | 4.13e-04 | 17 | 181 | 3 | GO:0048241 | |
| GeneOntologyBiologicalProcess | regulation of sulfur metabolic process | 4.13e-04 | 17 | 181 | 3 | GO:0042762 | |
| GeneOntologyBiologicalProcess | adult behavior | 4.39e-04 | 203 | 181 | 8 | GO:0030534 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 4.51e-04 | 41 | 181 | 4 | GO:1901020 | |
| GeneOntologyBiologicalProcess | regulation of sulfur amino acid metabolic process | 4.54e-04 | 4 | 181 | 2 | GO:0031335 | |
| GeneOntologyBiologicalProcess | cytoplasm organization | 4.92e-04 | 18 | 181 | 3 | GO:0007028 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 5.42e-04 | 43 | 181 | 4 | GO:0051953 | |
| GeneOntologyBiologicalProcess | lipid transport | DRD2 ATP8B4 CES1 SLC10A4 SLC13A3 ATP9B ATP8B2 CRHR1 CD36 ATP11C TMEM41B ABCC2 MAP2K6 | 5.48e-04 | 506 | 181 | 13 | GO:0006869 |
| GeneOntologyBiologicalProcess | modified amino acid transport | 5.92e-04 | 44 | 181 | 4 | GO:0072337 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1A XCR1 ATP13A4 DRD2 AVPR1A TMEM175 ABCB6 TRDN DMXL1 ITPR1 SLC8A1 THADA SLC12A4 ATP6AP2 KDR ABCC2 | 6.02e-04 | 717 | 181 | 16 | GO:0050801 |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 6.72e-04 | 120 | 181 | 6 | GO:0006835 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 7.02e-04 | 121 | 181 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A XCR1 ATP13A4 DRD2 PKD1L3 TRDN OPA1 CRHR1 ITPR1 SLC8A1 SLN | 7.16e-04 | 392 | 181 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | cellular response to diacyl bacterial lipopeptide | 7.53e-04 | 5 | 181 | 2 | GO:0071726 | |
| GeneOntologyBiologicalProcess | response to diacyl bacterial lipopeptide | 7.53e-04 | 5 | 181 | 2 | GO:0071724 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 7.98e-04 | 124 | 181 | 6 | GO:0034766 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 7.99e-04 | 171 | 181 | 7 | GO:0043271 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | APH1B ATP13A4 REEP1 CYP3A4 PIEZO1 SPPL3 FAXDC2 ABCB6 HACD2 TRDN REEP2 ATP8B2 ITPR1 NBAS THADA VKORC1 CNIH4 MTOR ATP6AP2 SLC35A2 SLN UGT2B10 UGT2B15 ATP11C TMEM39A TMEM41B OR7A17 RNF145 TAP1 HACD1 GABBR1 | 2.88e-07 | 1293 | 183 | 31 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | APH1B ATP13A4 REEP1 CYP3A4 PIEZO1 SPPL3 FAXDC2 ABCB6 HACD2 TRDN REEP2 ATP8B2 ITPR1 NBAS THADA VKORC1 CNIH4 MTOR ATP6AP2 SLC35A2 SLN UGT2B10 UGT2B15 ATP11C TMEM39A TMEM41B OR7A17 RNF145 TAP1 HACD1 GABBR1 | 3.19e-07 | 1299 | 183 | 31 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | APH1B ATP13A4 REEP1 CYP3A4 PIEZO1 SPPL3 FAXDC2 ABCB6 HACD2 TRDN REEP2 ATP8B2 ITPR1 NBAS THADA VKORC1 CNIH4 MTOR ATP6AP2 SLC35A2 SLN UGT2B10 UGT2B15 ATP11C TMEM39A TMEM41B OR7A17 RNF145 TAP1 HACD1 GABBR1 | 5.05e-07 | 1327 | 183 | 31 | GO:0042175 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.24e-04 | 14 | 183 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | neuronal cell body | DAB2IP CACNA1A PDE1A DRD2 HTR5A CHRNA3 CRHR1 CRHR2 ITPR1 SLC8A1 MTOR ACAN KDR WDFY3 IL6ST CNR2 GABBR1 SOS1 | 4.03e-04 | 835 | 183 | 18 | GO:0043025 |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP CACNA1A PDE1A DRD2 HTR5A ACTN1 OPA1 CHRNA3 CRHR1 CRHR2 OPHN1 ITPR1 SLC8A1 MTOR ATP6AP2 ACAN KDR WDFY3 EPHA10 IL6ST CNR2 GABBR1 SOS1 | 4.72e-04 | 1228 | 183 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | cell body | DAB2IP CACNA1A PDE1A DRD2 HTR5A CHRNA3 CRHR1 CRHR2 ITPR1 SLC8A1 MTOR ATP6AP2 ACAN KDR WDFY3 IL6ST CNR2 GABBR1 SOS1 | 5.30e-04 | 929 | 183 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | dendrite | DAB2IP CACNA1A DRD2 HTR5A ACTN1 OPA1 CHRNA3 CRHR1 CRHR2 OPHN1 ITPR1 SLC8A1 MTOR ATP6AP2 EPHA10 IL6ST CNR2 GABBR1 | 5.55e-04 | 858 | 183 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP CACNA1A DRD2 HTR5A ACTN1 OPA1 CHRNA3 CRHR1 CRHR2 OPHN1 ITPR1 SLC8A1 MTOR ATP6AP2 EPHA10 IL6ST CNR2 GABBR1 | 5.70e-04 | 860 | 183 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | receptor complex | PMP22 FLT1 DRD2 HTR3C TLR6 PKD1L3 TRDV2 CHRNA3 CD36 SLITRK5 KDR IL6ST GABBR1 TRAV13-1 | 6.21e-04 | 581 | 183 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | dopaminergic synapse | 8.99e-04 | 22 | 183 | 3 | GO:0098691 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A DRD2 HTR5A HTR3C NBEA CHRNA3 CRHR1 SLC8A1 ATP6AP2 SLITRK5 GABBR1 | 9.17e-04 | 405 | 183 | 11 | GO:0045211 |
| Domain | 14_3_3 | 4.17e-12 | 7 | 174 | 6 | SM00101 | |
| Domain | 1433_1 | 4.17e-12 | 7 | 174 | 6 | PS00796 | |
| Domain | 1433_2 | 4.17e-12 | 7 | 174 | 6 | PS00797 | |
| Domain | 14-3-3_domain | 4.17e-12 | 7 | 174 | 6 | IPR023410 | |
| Domain | 14-3-3_CS | 4.17e-12 | 7 | 174 | 6 | IPR023409 | |
| Domain | 14-3-3 | 4.17e-12 | 7 | 174 | 6 | PF00244 | |
| Domain | 14-3-3 | 1.65e-11 | 8 | 174 | 6 | IPR000308 | |
| Domain | GPCR_Rhodpsn_7TM | VN1R2 XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 PTGFR S1PR3 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 | 4.55e-06 | 670 | 174 | 20 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_1 | VN1R2 XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 PTGFR S1PR3 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 | 6.32e-06 | 685 | 174 | 20 | PS00237 |
| Domain | P_typ_ATPase_c | 6.77e-06 | 14 | 174 | 4 | IPR032630 | |
| Domain | P-type_ATPase_N | 6.77e-06 | 14 | 174 | 4 | IPR032631 | |
| Domain | P-type_ATPase_IV | 6.77e-06 | 14 | 174 | 4 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 6.77e-06 | 14 | 174 | 4 | PF16212 | |
| Domain | PhoLip_ATPase_N | 6.77e-06 | 14 | 174 | 4 | PF16209 | |
| Domain | G_PROTEIN_RECEP_F1_2 | VN1R2 XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 PTGFR S1PR3 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 | 7.18e-06 | 691 | 174 | 20 | PS50262 |
| Domain | GPCR_Rhodpsn | VN1R2 XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 PTGFR S1PR3 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 | 7.34e-06 | 692 | 174 | 20 | IPR000276 |
| Domain | Nuc_sug_transp | 7.84e-06 | 5 | 174 | 3 | PF04142 | |
| Domain | Nuc_sug_transpt | 7.84e-06 | 5 | 174 | 3 | IPR007271 | |
| Domain | - | 1.09e-05 | 32 | 174 | 5 | 3.40.1110.10 | |
| Domain | - | 1.09e-05 | 32 | 174 | 5 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.72e-05 | 35 | 174 | 5 | IPR023299 | |
| Domain | 7tm_1 | XCR1 OR10H5 DRD2 GPR65 HTR5A AVPR1A GPR82 OR4D1 OR2T10 PTGFR S1PR3 OR52I1 PROKR2 OR10H2 OR10H1 OR56A3 OR7A17 PTGDR2 CNR2 | 1.90e-05 | 677 | 174 | 19 | PF00001 |
| Domain | ATPase_P-typ_P_site | 1.98e-05 | 36 | 174 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 1.98e-05 | 36 | 174 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.98e-05 | 36 | 174 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.27e-05 | 37 | 174 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.27e-05 | 37 | 174 | 5 | PF00122 | |
| Domain | Sushi | 1.21e-04 | 52 | 174 | 5 | PF00084 | |
| Domain | CCP | 1.45e-04 | 54 | 174 | 5 | SM00032 | |
| Domain | SUSHI | 1.72e-04 | 56 | 174 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.87e-04 | 57 | 174 | 5 | IPR000436 | |
| Domain | GPCR_2_CRF_rcpt | 2.57e-04 | 3 | 174 | 2 | IPR003051 | |
| Domain | - | 3.24e-04 | 64 | 174 | 5 | 3.40.50.1000 | |
| Domain | PTPLA | 5.11e-04 | 4 | 174 | 2 | PF04387 | |
| Domain | EMP70 | 5.11e-04 | 4 | 174 | 2 | PF02990 | |
| Domain | Tyr_Pase-like_PTPLA | 5.11e-04 | 4 | 174 | 2 | IPR007482 | |
| Domain | EMP70 | 5.11e-04 | 4 | 174 | 2 | IPR004240 | |
| Domain | Na/sul_symport | 8.47e-04 | 5 | 174 | 2 | IPR001898 | |
| Domain | Choline_transpo | 8.47e-04 | 5 | 174 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 8.47e-04 | 5 | 174 | 2 | IPR007603 | |
| Domain | Na_sulph_symp | 8.47e-04 | 5 | 174 | 2 | PF00939 | |
| Domain | DUF4704 | 8.47e-04 | 5 | 174 | 2 | IPR031570 | |
| Domain | DUF4704 | 8.47e-04 | 5 | 174 | 2 | PF15787 | |
| Domain | HAD-like_dom | 8.56e-04 | 79 | 174 | 5 | IPR023214 | |
| Domain | AA-permease/SLC12A_dom | 1.07e-03 | 22 | 174 | 3 | IPR004841 | |
| Domain | AA_permease | 1.07e-03 | 22 | 174 | 3 | PF00324 | |
| Domain | ACTININ_2 | 1.23e-03 | 23 | 174 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.23e-03 | 23 | 174 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.23e-03 | 23 | 174 | 3 | IPR001589 | |
| Domain | PH_BEACH | 1.26e-03 | 6 | 174 | 2 | PF14844 | |
| Domain | TB2_DP1_HVA22 | 1.26e-03 | 6 | 174 | 2 | IPR004345 | |
| Domain | FAT | 1.26e-03 | 6 | 174 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.26e-03 | 6 | 174 | 2 | IPR003151 | |
| Domain | TB2_DP1_HVA22 | 1.26e-03 | 6 | 174 | 2 | PF03134 | |
| Domain | ABC_membrane | 1.39e-03 | 24 | 174 | 3 | PF00664 | |
| Domain | GP_PDE_dom | 1.76e-03 | 7 | 174 | 2 | IPR030395 | |
| Domain | GlyceroP-diester-Pdiesterase | 1.76e-03 | 7 | 174 | 2 | IPR004129 | |
| Domain | GDPD | 1.76e-03 | 7 | 174 | 2 | PF03009 | |
| Domain | GP_PDE | 1.76e-03 | 7 | 174 | 2 | PS51704 | |
| Domain | ABC_TM1F | 2.19e-03 | 28 | 174 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 2.19e-03 | 28 | 174 | 3 | IPR011527 | |
| Domain | Tyr_kinase_rcpt_3_CS | 2.33e-03 | 8 | 174 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 2.33e-03 | 8 | 174 | 2 | PS00240 | |
| Domain | PH-BEACH_dom | 2.33e-03 | 8 | 174 | 2 | IPR023362 | |
| Domain | - | 2.33e-03 | 8 | 174 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 2.33e-03 | 8 | 174 | 2 | PS51783 | |
| Domain | Ig_V-set | 2.67e-03 | 199 | 174 | 7 | IPR013106 | |
| Domain | BEACH | 2.98e-03 | 9 | 174 | 2 | PS50197 | |
| Domain | Beach | 2.98e-03 | 9 | 174 | 2 | PF02138 | |
| Domain | - | 2.98e-03 | 9 | 174 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.98e-03 | 9 | 174 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.98e-03 | 9 | 174 | 2 | IPR000409 | |
| Domain | PMP22_EMP_MP20 | 2.98e-03 | 9 | 174 | 2 | IPR004032 | |
| Domain | PMP22_2 | 2.98e-03 | 9 | 174 | 2 | PS01222 | |
| Domain | PMP22_1 | 2.98e-03 | 9 | 174 | 2 | PS01221 | |
| Domain | AA_permease_2 | 6.29e-03 | 13 | 174 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 6.29e-03 | 13 | 174 | 2 | IPR002293 | |
| Domain | ABC_transporter_CS | 6.99e-03 | 42 | 174 | 3 | IPR017871 | |
| Domain | V-set | 7.63e-03 | 184 | 174 | 6 | PF07686 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 6.36e-10 | 12 | 136 | 6 | MM14482 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 6.36e-10 | 12 | 136 | 6 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 6.36e-10 | 12 | 136 | 6 | MM15443 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 1.17e-09 | 13 | 136 | 6 | M27708 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.36e-09 | 15 | 136 | 6 | M26902 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 5.34e-09 | 16 | 136 | 6 | M46428 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.22e-08 | 18 | 136 | 6 | MM14510 | |
| Pathway | PID_P38_MK2_PATHWAY | 3.48e-08 | 21 | 136 | 6 | M199 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 3.58e-08 | 35 | 136 | 7 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 4.40e-08 | 36 | 136 | 7 | M271 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 5.82e-08 | 12 | 136 | 5 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 5.82e-08 | 12 | 136 | 5 | M27939 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 6.37e-08 | 23 | 136 | 6 | MM15216 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 9.39e-08 | 13 | 136 | 5 | M47589 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 1.42e-07 | 26 | 136 | 6 | M247 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 2.47e-07 | 67 | 136 | 8 | M295 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 2.61e-07 | 46 | 136 | 7 | M239 | |
| Pathway | PID_LKB1_PATHWAY | 3.04e-07 | 47 | 136 | 7 | M87 | |
| Pathway | PID_MTOR_4PATHWAY | 3.11e-07 | 69 | 136 | 8 | M121 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 3.54e-07 | 30 | 136 | 6 | M17814 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC39A2 SLC35A1 SLC44A2 SLC13A3 SLC7A11 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 SLC2A12 | 5.03e-07 | 238 | 136 | 13 | MM15076 |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 5.41e-07 | 51 | 136 | 7 | M7955 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC39A2 SLC35A1 SLC44A2 SLC13A3 SLC7A11 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 SLC2A12 | 8.40e-07 | 249 | 136 | 13 | M5988 |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 1.40e-06 | 21 | 136 | 5 | M48088 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.79e-06 | 22 | 136 | 5 | MM15656 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP13A4 ATP8B4 SLC39A2 SLC35A1 SLC44A2 ABCB6 SLC13A3 ATP9B SLC7A11 TRDN ATP8B2 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 SLN ATP11C ABCC2 SLC2A12 | 2.05e-06 | 736 | 136 | 22 | M27287 |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 2.12e-06 | 40 | 136 | 6 | MM14473 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP13A4 ATP8B4 SLC39A2 SLC35A1 SLC44A2 ABCB6 SLC13A3 ATP9B SLC7A11 TRDN ATP8B2 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 ATP11C ABCC2 SLC2A12 | 2.21e-06 | 681 | 136 | 21 | MM14985 |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 5.82e-06 | 72 | 136 | 7 | M26954 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 5.82e-06 | 72 | 136 | 7 | MM15381 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 6.39e-06 | 73 | 136 | 7 | MM15223 | |
| Pathway | PID_FOXO_PATHWAY | 7.18e-06 | 49 | 136 | 6 | M136 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 7.75e-06 | 105 | 136 | 8 | M164 | |
| Pathway | WP_GPCRS_NONODORANT | XCR1 DRD2 GPR65 HTR5A AVPR1A PTGFR S1PR3 CRHR1 CRHR2 PROKR2 CNR2 GABBR1 | 1.01e-05 | 266 | 136 | 12 | MM15843 |
| Pathway | PID_NFAT_3PATHWAY | 1.14e-05 | 53 | 136 | 6 | M113 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.24e-05 | 147 | 136 | 9 | MM15854 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.42e-05 | 55 | 136 | 6 | M7455 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.42e-05 | 55 | 136 | 6 | M971 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.54e-05 | 151 | 136 | 9 | M39329 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.63e-05 | 84 | 136 | 7 | M27495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 1.72e-05 | 6 | 136 | 3 | M47880 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.80e-05 | 154 | 136 | 9 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.00e-05 | 156 | 136 | 9 | M39475 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 3.39e-05 | 94 | 136 | 7 | M1080 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | XCR1 DRD2 GPR65 HTR5A AVPR1A PTGFR OR10H2 OR10H1 OR7A17 PTGDR2 CNR2 | 4.33e-05 | 260 | 136 | 11 | M39397 |
| Pathway | REACTOME_ASPIRIN_ADME | 6.23e-05 | 44 | 136 | 5 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.96e-05 | 45 | 136 | 5 | MM15694 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | XCR1 DRD2 GPR65 HTR5A AVPR1A TAS2R38 PTGFR S1PR3 CRHR1 CRHR2 PROKR2 PTGDR2 CNR2 GABBR1 | 7.00e-05 | 430 | 136 | 14 | MM15160 |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 7.07e-05 | 9 | 136 | 3 | M27688 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 7.07e-05 | 9 | 136 | 3 | MM15421 | |
| Pathway | REACTOME_APOPTOSIS | 8.26e-05 | 108 | 136 | 7 | MM14471 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 9.07e-05 | 76 | 136 | 6 | MM15072 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.21e-04 | 80 | 136 | 6 | M223 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | XCR1 PDE1A DRD2 GPR65 HTR5A AVPR1A NBEA TAS2R38 PTGFR S1PR3 CRHR1 CRHR2 ITPR1 PROKR2 PTGDR2 CNR2 GABBR1 SOS1 | 1.40e-04 | 702 | 136 | 18 | M746 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | XCR1 DRD2 GPR65 HTR5A AVPR1A TAS2R38 PTGFR S1PR3 CRHR1 CRHR2 PROKR2 PTGDR2 CNR2 GABBR1 | 1.53e-04 | 463 | 136 | 14 | M507 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.58e-04 | 84 | 136 | 6 | M27334 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | XCR1 PDE1A DRD2 GPR65 HTR5A AVPR1A TAS2R38 PTGFR S1PR3 CRHR1 CRHR2 ITPR1 PROKR2 PTGDR2 CNR2 GABBR1 SOS1 | 1.59e-04 | 646 | 136 | 17 | MM14962 |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.81e-04 | 12 | 136 | 3 | M39611 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.17e-04 | 57 | 136 | 5 | MM15643 | |
| Pathway | PID_PDGFRB_PATHWAY | 2.51e-04 | 129 | 136 | 7 | M186 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.77e-04 | 93 | 136 | 6 | M27487 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | DRD2 HTR5A AVPR1A PTGFR S1PR3 CHRNA3 CRHR1 CRHR2 CNR2 GABBR1 | 3.05e-04 | 272 | 136 | 10 | M13380 |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 3.17e-04 | 177 | 136 | 8 | M27476 | |
| Pathway | REACTOME_SARS_COV_1_HOST_INTERACTIONS | 3.67e-04 | 98 | 136 | 6 | M46424 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.88e-04 | 99 | 136 | 6 | M27474 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 4.33e-04 | 66 | 136 | 5 | MM15925 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 4.33e-04 | 66 | 136 | 5 | M27938 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.42e-04 | 186 | 136 | 8 | MM15994 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 4.49e-04 | 142 | 136 | 7 | MM15178 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 4.69e-04 | 143 | 136 | 7 | MM15383 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 6.45e-04 | 18 | 136 | 3 | MM15858 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 7.60e-04 | 19 | 136 | 3 | M39728 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 7.84e-04 | 113 | 136 | 6 | M16817 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 9.07e-04 | 5 | 136 | 2 | MM15099 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 9.07e-04 | 5 | 136 | 2 | M27354 | |
| Pathway | WP_CELL_CYCLE | 1.07e-03 | 120 | 136 | 6 | M39650 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.17e-03 | 167 | 136 | 7 | M19381 | |
| Pathway | KEGG_CELL_CYCLE | 1.32e-03 | 125 | 136 | 6 | M7963 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.35e-03 | 23 | 136 | 3 | MM16639 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.36e-03 | 330 | 136 | 10 | M18334 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.38e-03 | 126 | 136 | 6 | M16763 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.45e-03 | 333 | 136 | 10 | MM14963 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.46e-03 | 51 | 136 | 4 | M17726 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.62e-03 | 130 | 136 | 6 | M27454 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.69e-03 | 178 | 136 | 7 | M2890 | |
| Pathway | REACTOME_APOPTOSIS | 1.75e-03 | 179 | 136 | 7 | M15303 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.80e-03 | 54 | 136 | 4 | M27460 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.98e-03 | 183 | 136 | 7 | M997 | |
| Pathway | WP_NRF2_PATHWAY | 2.44e-03 | 141 | 136 | 6 | M39454 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 2.49e-03 | 8 | 136 | 2 | MM14753 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 2.49e-03 | 8 | 136 | 2 | M710 | |
| Pubmed | 1.32e-13 | 7 | 182 | 6 | 31906564 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 1.32e-13 | 7 | 182 | 6 | 20388496 | |
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 1.32e-13 | 7 | 182 | 6 | 12383250 | |
| Pubmed | 5.25e-13 | 8 | 182 | 6 | 16045749 | ||
| Pubmed | 5.25e-13 | 8 | 182 | 6 | 18332103 | ||
| Pubmed | 1.57e-12 | 9 | 182 | 6 | 16581770 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 1.57e-12 | 9 | 182 | 6 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 1.57e-12 | 9 | 182 | 6 | 12438239 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 1.57e-12 | 9 | 182 | 6 | 16511560 | |
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 1.57e-12 | 9 | 182 | 6 | 34294877 | |
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 3.90e-12 | 10 | 182 | 6 | 14505491 | |
| Pubmed | 3.90e-12 | 10 | 182 | 6 | 12433946 | ||
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 3.90e-12 | 10 | 182 | 6 | 25154416 | |
| Pubmed | 3.90e-12 | 10 | 182 | 6 | 20478393 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 3.90e-12 | 10 | 182 | 6 | 15791647 | |
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 3.90e-12 | 10 | 182 | 6 | 11697890 | |
| Pubmed | 8.55e-12 | 11 | 182 | 6 | 15696159 | ||
| Pubmed | 1.70e-11 | 12 | 182 | 6 | 39406751 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 1.70e-11 | 12 | 182 | 6 | 19172738 | |
| Pubmed | 2.22e-11 | 6 | 182 | 5 | 16672277 | ||
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 2.22e-11 | 6 | 182 | 5 | 19860830 | |
| Pubmed | 3.15e-11 | 13 | 182 | 6 | 22222486 | ||
| Pubmed | 3.15e-11 | 13 | 182 | 6 | 19014373 | ||
| Pubmed | 5.48e-11 | 14 | 182 | 6 | 16093354 | ||
| Pubmed | SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | 5.48e-11 | 14 | 182 | 6 | 33761321 | |
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 7.73e-11 | 7 | 182 | 5 | 15023544 | |
| Pubmed | 7.73e-11 | 7 | 182 | 5 | 22588126 | ||
| Pubmed | 7.73e-11 | 7 | 182 | 5 | 10620507 | ||
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 7.73e-11 | 7 | 182 | 5 | 36096339 | |
| Pubmed | 7.73e-11 | 7 | 182 | 5 | 27030597 | ||
| Pubmed | 7.73e-11 | 7 | 182 | 5 | 16868027 | ||
| Pubmed | SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. | 7.73e-11 | 7 | 182 | 5 | 19640509 | |
| Pubmed | 7.73e-11 | 7 | 182 | 5 | 21390248 | ||
| Pubmed | 9.10e-11 | 15 | 182 | 6 | 23572552 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 9.10e-11 | 15 | 182 | 6 | 16041367 | |
| Pubmed | 2.05e-10 | 8 | 182 | 5 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 2.05e-10 | 8 | 182 | 5 | 9524113 | |
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 2.05e-10 | 8 | 182 | 5 | 23622247 | |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 3.33e-10 | 18 | 182 | 6 | 30240640 | |
| Pubmed | 4.60e-10 | 9 | 182 | 5 | 18458160 | ||
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 4.60e-10 | 9 | 182 | 5 | 12176984 | |
| Pubmed | 4.60e-10 | 9 | 182 | 5 | 12446771 | ||
| Pubmed | Dermal fibroblasts influence the expression profile of 14-3-3 proteins in human keratinocytes. | 7.26e-10 | 4 | 182 | 4 | 21416292 | |
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 8515476 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | B3GALNT1 TM9SF1 PIEZO1 TMEM161B NAGA SLC35A1 HACD2 SLC7A11 YWHAB YWHAG DMXL1 ITPR1 GPR180 THADA TM9SF2 CNIH4 ATP6AP2 TMEM245 SLC35A2 SLITRK5 TWSG1 TMEM41B TAP1 PLS3 IL6ST FKBP14 | 9.62e-10 | 1201 | 182 | 26 | 35696571 |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 18779327 | ||
| Pubmed | BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. | 2.86e-09 | 12 | 182 | 5 | 29686263 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 20642453 | ||
| Pubmed | 3.61e-09 | 5 | 182 | 4 | 12364343 | ||
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 3.61e-09 | 5 | 182 | 4 | 19173300 | |
| Pubmed | Structural basis for protein-protein interactions in the 14-3-3 protein family. | 3.61e-09 | 5 | 182 | 4 | 17085597 | |
| Pubmed | Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. | 3.61e-09 | 5 | 182 | 4 | 11886850 | |
| Pubmed | 3.61e-09 | 5 | 182 | 4 | 23938468 | ||
| Pubmed | 4.62e-09 | 13 | 182 | 5 | 34654719 | ||
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 15265780 | ||
| Pubmed | 7.16e-09 | 14 | 182 | 5 | 12919677 | ||
| Pubmed | AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. | 7.16e-09 | 14 | 182 | 5 | 36806887 | |
| Pubmed | 1.08e-08 | 6 | 182 | 4 | 16613846 | ||
| Pubmed | Uncoupling proteins 2 and 3 interact with members of the 14.3.3 family. | 1.08e-08 | 6 | 182 | 4 | 10785390 | |
| Pubmed | 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. | 1.08e-08 | 6 | 182 | 4 | 11864996 | |
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 1.08e-08 | 6 | 182 | 4 | 10713667 | |
| Pubmed | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. | 1.55e-08 | 16 | 182 | 5 | 23071090 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 2.18e-08 | 17 | 182 | 5 | 37045861 | |
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 2.51e-08 | 7 | 182 | 4 | 15883043 | |
| Pubmed | 2.51e-08 | 7 | 182 | 4 | 10441394 | ||
| Pubmed | Identification of five novel 14-3-3 isoforms interacting with the GPIb-IX complex in platelets. | 2.51e-08 | 7 | 182 | 4 | 19558434 | |
| Pubmed | Inhibitory interaction of the plasma membrane Na+/Ca2+ exchangers with the 14-3-3 proteins. | 2.51e-08 | 7 | 182 | 4 | 16679322 | |
| Pubmed | 2.51e-08 | 7 | 182 | 4 | 15159416 | ||
| Pubmed | 4.07e-08 | 19 | 182 | 5 | 35343654 | ||
| Pubmed | Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. | 5.00e-08 | 8 | 182 | 4 | 23075850 | |
| Pubmed | 5.00e-08 | 8 | 182 | 4 | 8702721 | ||
| Pubmed | Analysis of phosphorylation-dependent protein-protein interactions of histone h3. | 7.06e-08 | 21 | 182 | 5 | 25330109 | |
| Pubmed | 8.48e-08 | 42 | 182 | 6 | 23444366 | ||
| Pubmed | The structural basis for 14-3-3:phosphopeptide binding specificity. | 1.41e-07 | 3 | 182 | 3 | 9428519 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 8617504 | ||
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 8037685 | ||
| Pubmed | C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. | 1.41e-07 | 3 | 182 | 3 | 23728178 | |
| Pubmed | 1.81e-07 | 25 | 182 | 5 | 21145499 | ||
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 2.40e-07 | 81 | 182 | 7 | 20697350 | |
| Pubmed | 3.31e-07 | 28 | 182 | 5 | 20012529 | ||
| Pubmed | Peli1 Modulates the Subcellular Localization and Activity of Mdmx. | 3.48e-07 | 12 | 182 | 4 | 29523541 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | TM9SF1 PIEZO1 TMEM175 SLC44A2 SLC7A11 S1PR3 VKORC1 TM9SF2 SLC12A4 TMEM87B CEP44 TMEM245 SLC35A2 TAP1 | 4.37e-07 | 499 | 182 | 14 | 22810586 |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 5.00e-07 | 13 | 182 | 4 | 11015572 | |
| Pubmed | 5.00e-07 | 13 | 182 | 4 | 23177959 | ||
| Pubmed | 5.50e-07 | 57 | 182 | 6 | 29089450 | ||
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 9705322 | ||
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 28202711 | ||
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 24269678 | ||
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 11996670 | ||
| Pubmed | Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. | 5.62e-07 | 4 | 182 | 3 | 12507503 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 16968670 | ||
| Pubmed | CPAP interacts with 14-3-3 in a cell cycle-dependent manner. | 5.62e-07 | 4 | 182 | 3 | 16516142 | |
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 11985497 | ||
| Pubmed | Aurora B and 14-3-3 coordinately regulate clustering of centralspindlin during cytokinesis. | 1.40e-06 | 5 | 182 | 3 | 20451386 | |
| Pubmed | Factor H-related proteins determine complement-activating surfaces. | 1.40e-06 | 5 | 182 | 3 | 25979655 | |
| Pubmed | The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. | 1.40e-06 | 5 | 182 | 3 | 9197417 | |
| Pubmed | A Cdc2-related protein kinase hPFTAIRE1 from human brain interacting with 14-3-3 proteins. | 1.40e-06 | 5 | 182 | 3 | 16775625 | |
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 21228155 | ||
| Pubmed | 1.45e-06 | 67 | 182 | 6 | 29357390 | ||
| Pubmed | Systematic identification of pathological lamin A interactors. | PMP22 TMEM60 SLC35A1 FAXDC2 SLC13A3 CFHR5 ZDHHC24 VKORC1 SLN TAP1 HACD1 | 1.84e-06 | 337 | 182 | 11 | 24623722 |
| Interaction | REEP3 interactions | 1.05e-11 | 34 | 176 | 9 | int:REEP3 | |
| Interaction | KCNK15 interactions | 1.12e-11 | 8 | 176 | 6 | int:KCNK15 | |
| Interaction | KCNK9 interactions | 3.35e-11 | 9 | 176 | 6 | int:KCNK9 | |
| Interaction | FAM163A interactions | 1.59e-10 | 19 | 176 | 7 | int:FAM163A | |
| Interaction | PPP1R3E interactions | 3.60e-10 | 12 | 176 | 6 | int:PPP1R3E | |
| Interaction | KCNK3 interactions | 6.64e-10 | 13 | 176 | 6 | int:KCNK3 | |
| Interaction | SAMSN1 interactions | 3.03e-09 | 16 | 176 | 6 | int:SAMSN1 | |
| Interaction | KIAA0930 interactions | 3.49e-09 | 28 | 176 | 7 | int:KIAA0930 | |
| Interaction | DENND2B interactions | 3.49e-09 | 28 | 176 | 7 | int:DENND2B | |
| Interaction | FAM53B interactions | 6.93e-09 | 18 | 176 | 6 | int:FAM53B | |
| Interaction | OTOG interactions | 1.17e-08 | 10 | 176 | 5 | int:OTOG | |
| Interaction | MLXIP interactions | 1.43e-08 | 20 | 176 | 6 | int:MLXIP | |
| Interaction | REEP4 interactions | PMP22 REEP1 TMEM60 SPPL3 YWHAB REEP2 YWHAG YWHAH YWHAZ KLRK1 SLC44A5 YWHAQ SFN | 1.54e-08 | 193 | 176 | 13 | int:REEP4 |
| Interaction | SPATA13 interactions | 1.98e-08 | 21 | 176 | 6 | int:SPATA13 | |
| Interaction | SPIRE2 interactions | 1.98e-08 | 21 | 176 | 6 | int:SPIRE2 | |
| Interaction | STOX2 interactions | 1.98e-08 | 21 | 176 | 6 | int:STOX2 | |
| Interaction | DENND1B interactions | 1.98e-08 | 21 | 176 | 6 | int:DENND1B | |
| Interaction | CDCA7 interactions | 2.12e-08 | 11 | 176 | 5 | int:CDCA7 | |
| Interaction | PPP4R4 interactions | 2.71e-08 | 22 | 176 | 6 | int:PPP4R4 | |
| Interaction | PPP1R3D interactions | 2.71e-08 | 22 | 176 | 6 | int:PPP1R3D | |
| Interaction | TNK1 interactions | 3.45e-08 | 38 | 176 | 7 | int:TNK1 | |
| Interaction | GNGT2 interactions | 3.62e-08 | 12 | 176 | 5 | int:GNGT2 | |
| Interaction | CCSER1 interactions | 3.63e-08 | 23 | 176 | 6 | int:CCSER1 | |
| Interaction | PRR5 interactions | 4.18e-08 | 39 | 176 | 7 | int:PRR5 | |
| Interaction | PACS2 interactions | 4.81e-08 | 24 | 176 | 6 | int:PACS2 | |
| Interaction | C6orf132 interactions | 6.29e-08 | 25 | 176 | 6 | int:C6orf132 | |
| Interaction | TMCC1 interactions | 6.29e-08 | 25 | 176 | 6 | int:TMCC1 | |
| Interaction | TTYH1 interactions | SLC16A13 DRD2 TMEM60 PIEZO1 TMEM161B TMEM175 PHTF2 ABCB6 HACD2 ATP8B2 TMEM179B SLC12A4 SLC44A5 ATP11C TMEM39A | 6.40e-08 | 300 | 176 | 15 | int:TTYH1 |
| Interaction | MAST4 interactions | 8.11e-08 | 26 | 176 | 6 | int:MAST4 | |
| Interaction | FAM83G interactions | 8.11e-08 | 26 | 176 | 6 | int:FAM83G | |
| Interaction | SSH2 interactions | 8.50e-08 | 43 | 176 | 7 | int:SSH2 | |
| Interaction | GCKR interactions | 9.01e-08 | 14 | 176 | 5 | int:GCKR | |
| Interaction | SPIRE1 interactions | 1.04e-07 | 27 | 176 | 6 | int:SPIRE1 | |
| Interaction | RGS12 interactions | 1.18e-07 | 45 | 176 | 7 | int:RGS12 | |
| Interaction | SPATA18 interactions | 1.31e-07 | 28 | 176 | 6 | int:SPATA18 | |
| Interaction | USP31 interactions | 1.31e-07 | 28 | 176 | 6 | int:USP31 | |
| Interaction | WWC2 interactions | 1.31e-07 | 28 | 176 | 6 | int:WWC2 | |
| Interaction | FAM13A interactions | 1.64e-07 | 29 | 176 | 6 | int:FAM13A | |
| Interaction | TESPA1 interactions | 1.94e-07 | 16 | 176 | 5 | int:TESPA1 | |
| Interaction | ZFP36L1 interactions | 2.03e-07 | 30 | 176 | 6 | int:ZFP36L1 | |
| Interaction | ARAP2 interactions | 2.03e-07 | 30 | 176 | 6 | int:ARAP2 | |
| Interaction | TICRR interactions | 2.03e-07 | 30 | 176 | 6 | int:TICRR | |
| Interaction | PABIR1 interactions | 2.50e-07 | 31 | 176 | 6 | int:PABIR1 | |
| Interaction | CRTC1 interactions | 2.50e-07 | 31 | 176 | 6 | int:CRTC1 | |
| Interaction | ZNF395 interactions | 2.73e-07 | 17 | 176 | 5 | int:ZNF395 | |
| Interaction | AKT1S1 interactions | 3.06e-07 | 32 | 176 | 6 | int:AKT1S1 | |
| Interaction | CEP112 interactions | 3.06e-07 | 32 | 176 | 6 | int:CEP112 | |
| Interaction | KIF26B interactions | 3.30e-07 | 52 | 176 | 7 | int:KIF26B | |
| Interaction | FRMD6 interactions | 3.78e-07 | 53 | 176 | 7 | int:FRMD6 | |
| Interaction | LYST interactions | 3.78e-07 | 53 | 176 | 7 | int:LYST | |
| Interaction | KCNQ5 interactions | 4.47e-07 | 34 | 176 | 6 | int:KCNQ5 | |
| Interaction | SMTNL2 interactions | 5.36e-07 | 35 | 176 | 6 | int:SMTNL2 | |
| Interaction | FAM86C1P interactions | 5.36e-07 | 35 | 176 | 6 | int:FAM86C1P | |
| Interaction | PARP8 interactions | 6.69e-07 | 20 | 176 | 5 | int:PARP8 | |
| Interaction | PPP1R12C interactions | 7.10e-07 | 58 | 176 | 7 | int:PPP1R12C | |
| Interaction | RUSC2 interactions | 8.92e-07 | 38 | 176 | 6 | int:RUSC2 | |
| Interaction | PI4KB interactions | 8.99e-07 | 60 | 176 | 7 | int:PI4KB | |
| Interaction | TMCC3 interactions | 1.05e-06 | 39 | 176 | 6 | int:TMCC3 | |
| Interaction | ATAT1 interactions | 1.12e-06 | 22 | 176 | 5 | int:ATAT1 | |
| Interaction | FAM117B interactions | 1.22e-06 | 40 | 176 | 6 | int:FAM117B | |
| Interaction | PABIR2 interactions | 1.22e-06 | 40 | 176 | 6 | int:PABIR2 | |
| Interaction | FGD6 interactions | 1.22e-06 | 40 | 176 | 6 | int:FGD6 | |
| Interaction | NKD2 interactions | 1.22e-06 | 40 | 176 | 6 | int:NKD2 | |
| Interaction | SIPA1 interactions | 1.42e-06 | 41 | 176 | 6 | int:SIPA1 | |
| Interaction | INPP5F interactions | 1.42e-06 | 41 | 176 | 6 | int:INPP5F | |
| Interaction | GLCCI1 interactions | 1.42e-06 | 23 | 176 | 5 | int:GLCCI1 | |
| Interaction | TPD52L1 interactions | 1.65e-06 | 42 | 176 | 6 | int:TPD52L1 | |
| Interaction | ARHGEF28 interactions | 1.65e-06 | 42 | 176 | 6 | int:ARHGEF28 | |
| Interaction | E2F8 interactions | 1.78e-06 | 24 | 176 | 5 | int:E2F8 | |
| Interaction | IRS2 interactions | 1.84e-06 | 95 | 176 | 8 | int:IRS2 | |
| Interaction | NAV2 interactions | 1.90e-06 | 43 | 176 | 6 | int:NAV2 | |
| Interaction | REEP2 interactions | 2.13e-06 | 68 | 176 | 7 | int:REEP2 | |
| Interaction | SAMD4A interactions | 2.18e-06 | 44 | 176 | 6 | int:SAMD4A | |
| Interaction | DMTN interactions | 2.18e-06 | 44 | 176 | 6 | int:DMTN | |
| Interaction | LNP1 interactions | 2.21e-06 | 25 | 176 | 5 | int:LNP1 | |
| Interaction | TMEM102 interactions | 2.21e-06 | 25 | 176 | 5 | int:TMEM102 | |
| Interaction | UAP1 interactions | 2.50e-06 | 45 | 176 | 6 | int:UAP1 | |
| Interaction | PDE7B interactions | 2.63e-06 | 12 | 176 | 4 | int:PDE7B | |
| Interaction | REM1 interactions | 2.63e-06 | 12 | 176 | 4 | int:REM1 | |
| Interaction | PLEKHM3 interactions | 2.72e-06 | 26 | 176 | 5 | int:PLEKHM3 | |
| Interaction | CGNL1 interactions | 2.86e-06 | 46 | 176 | 6 | int:CGNL1 | |
| Interaction | PARD3B interactions | 2.86e-06 | 46 | 176 | 6 | int:PARD3B | |
| Interaction | RASSF2 interactions | 3.25e-06 | 47 | 176 | 6 | int:RASSF2 | |
| Interaction | DAB2IP interactions | 3.39e-06 | 103 | 176 | 8 | int:DAB2IP | |
| Interaction | MTMR12 interactions | 3.69e-06 | 48 | 176 | 6 | int:MTMR12 | |
| Interaction | NHS interactions | 3.69e-06 | 48 | 176 | 6 | int:NHS | |
| Interaction | PANK3 interactions | 3.78e-06 | 13 | 176 | 4 | int:PANK3 | |
| Interaction | DENND2C interactions | 3.78e-06 | 13 | 176 | 4 | int:DENND2C | |
| Interaction | RAPGEF2 interactions | 3.91e-06 | 105 | 176 | 8 | int:RAPGEF2 | |
| Interaction | CARMIL2 interactions | 4.01e-06 | 28 | 176 | 5 | int:CARMIL2 | |
| Interaction | MTSS2 interactions | 4.17e-06 | 49 | 176 | 6 | int:MTSS2 | |
| Interaction | PHLDB1 interactions | 4.17e-06 | 49 | 176 | 6 | int:PHLDB1 | |
| Interaction | N4BP3 interactions | 4.71e-06 | 50 | 176 | 6 | int:N4BP3 | |
| Interaction | CEP95 interactions | 4.71e-06 | 50 | 176 | 6 | int:CEP95 | |
| Interaction | NFATC3 interactions | 4.71e-06 | 50 | 176 | 6 | int:NFATC3 | |
| Interaction | MIIP interactions | 4.71e-06 | 50 | 176 | 6 | int:MIIP | |
| Interaction | SASH1 interactions | 4.71e-06 | 50 | 176 | 6 | int:SASH1 | |
| Interaction | SPEG interactions | 4.81e-06 | 29 | 176 | 5 | int:SPEG | |
| Interaction | SH3RF1 interactions | 4.83e-06 | 108 | 176 | 8 | int:SH3RF1 | |
| Interaction | TRAK1 interactions | 4.94e-06 | 77 | 176 | 7 | int:TRAK1 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 9.40e-13 | 7 | 132 | 6 | 1053 | |
| GeneFamily | Solute carriers | SLC16A13 SLC39A2 SLC6A17 SLC10A4 SLC35A1 SLC19A2 SLC44A2 SLC13A3 SLC7A11 SLC7A14 SLC25A3 SLC8A1 SLC35A3 SLC12A4 SLC44A5 SLC13A1 SLC22A5 SLC35A2 SLC38A11 SLC2A12 | 9.45e-12 | 395 | 132 | 20 | 752 |
| GeneFamily | ATPase phospholipid transporting | 3.48e-06 | 15 | 132 | 4 | 1210 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.61e-06 | 57 | 132 | 6 | 1179 | |
| GeneFamily | Corticotropin releasing hormone receptors | 5.29e-05 | 2 | 132 | 2 | 266 | |
| GeneFamily | Transmembrane 9 superfamily members | 3.14e-04 | 4 | 132 | 2 | 1239 | |
| GeneFamily | Receptor accessory proteins | 7.78e-04 | 6 | 132 | 2 | 717 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.26e-03 | 163 | 132 | 6 | 590 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.84e-03 | 9 | 132 | 2 | 1230 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 1.84e-03 | 9 | 132 | 2 | 207 | |
| GeneFamily | Complement system|Sushi domain containing | 2.28e-03 | 36 | 132 | 3 | 492 | |
| GeneFamily | ATP binding cassette subfamily B | 2.79e-03 | 11 | 132 | 2 | 806 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.31e-03 | 41 | 132 | 3 | 1298 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 8.69e-07 | 26 | 181 | 5 | M1380 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP | 1.02e-05 | 198 | 181 | 9 | M6166 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP | 1.07e-05 | 199 | 181 | 9 | M9491 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC16A13 TMEM158 TM9SF1 PIEZO1 SPPL3 SLC19A2 SLC44A2 HACD2 S1PR3 ZDHHC24 TM9SF2 SLC12A4 TMEM245 SLC35A2 TMEM41B IL6ST | 2.19e-05 | 681 | 181 | 16 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC16A13 TMEM158 TM9SF1 PIEZO1 SPPL3 SLC19A2 SLC44A2 HACD2 S1PR3 ZDHHC24 TM9SF2 SLC12A4 TMEM245 SLC35A2 TMEM41B IL6ST | 3.22e-05 | 703 | 181 | 16 | MM1055 |
| Coexpression | HOFFMAN_CLOCK_TARGETS_UP | 3.75e-05 | 10 | 181 | 3 | M2063 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | DAB2IP FLT1 SLC44A2 SLC7A11 ADAMTS9 CD36 LHFPL2 KDR ELK3 EMP1 IL6ST | 4.66e-05 | 362 | 181 | 11 | M39176 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | PMP22 CACNA1A ATP13A4 ABCB6 EBF1 GALNT13 TMTC1 INTS2 MTOR TMEM87B CNR2 | 4.77e-05 | 363 | 181 | 11 | M6315 |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 4.94e-05 | 187 | 181 | 8 | M7123 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | PMP22 CACNA1A ATP13A4 ABCB6 EBF1 GALNT13 TMTC1 INTS2 MTOR TMEM87B CNR2 | 5.94e-05 | 372 | 181 | 11 | MM1043 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | PMP22 CACNA1A RNF130 FLT1 YWHAZ ITPR1 SLC25A3 SLC12A4 EMP1 MAP2K6 IL6ST | 7.02e-05 | 379 | 181 | 11 | M1885 |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN | 7.64e-05 | 199 | 181 | 8 | M9543 | |
| Coexpression | GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 7.91e-05 | 200 | 181 | 8 | M3275 | |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 7.91e-05 | 200 | 181 | 8 | M322 | |
| Coexpression | RAMALHO_STEMNESS_UP | 8.78e-05 | 203 | 181 | 8 | MM1017 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 9.29e-05 | 152 | 181 | 7 | M39243 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | 1.12e-04 | 269 | 181 | 9 | M39114 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-2 | APH1B XCR1 FLT1 NAGA TMEM176A ITPR1 KLRK1 SLC8A1 CD36 KDR TMEM39A WDFY3 MAP2K6 CNR2 | 8.01e-06 | 407 | 176 | 14 | GSM538258_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_200 | 8.61e-06 | 88 | 176 | 7 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | PDE1A AVPR1A CES1 NAGA TMEM176A SLC13A3 EBF1 HACD2 PTGFR ITPR1 SLC8A1 SLC35A3 SLC13A1 CD36 SLC22A5 UGT2B10 UGT2B15 WDFY3 ABCC2 PLS1 | 1.11e-05 | 799 | 176 | 20 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | B3GALNT1 MYH3 PDE1A AVPR1A SLC6A17 NAGA PHTF2 EBF1 ACTN1 PTGFR S1PR3 ITPR1 SLC8A1 ADAMTS9 ACAN UGT2B15 WDFY3 ABCC2 PLS1 PLS3 IL6ST | 2.06e-05 | 905 | 176 | 21 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | APH1B XCR1 FLT1 GPR65 NAGA ITPR1 KLRK1 SLC8A1 CD36 TMEM39A WDFY3 MAP2K6 CNR2 | 4.17e-05 | 412 | 176 | 13 | GSM538260_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_200 | 1.13e-04 | 176 | 176 | 8 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | APH1B XCR1 FLT1 GPR65 NAGA GPR82 KLRK1 SLC8A1 CD36 WDFY3 MAP2K6 CNR2 | 1.24e-04 | 397 | 176 | 12 | GSM605827_500 |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE1A REEP1 PIEZO1 RUNX1T1 PKD1L3 TMTC1 ADAMTS9 CD36 KDR ELK3 | 9.20e-09 | 196 | 183 | 10 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE1A REEP1 PIEZO1 RUNX1T1 PKD1L3 TMTC1 ADAMTS9 CD36 KDR ELK3 | 9.20e-09 | 196 | 183 | 10 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-08 | 103 | 183 | 8 | d8965b338b90ddc0686ea0d94e9a330128566c39 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.52e-08 | 187 | 183 | 9 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 8.52e-08 | 187 | 183 | 9 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 9.76e-08 | 190 | 183 | 9 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 193 | 183 | 9 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 193 | 183 | 9 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.51e-07 | 200 | 183 | 9 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.55e-07 | 161 | 183 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 5.61e-07 | 171 | 183 | 8 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.40e-07 | 174 | 183 | 8 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-07 | 178 | 183 | 8 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 7.60e-07 | 178 | 183 | 8 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 7.93e-07 | 179 | 183 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.99e-07 | 182 | 183 | 8 | d996ceb77c83591df4cef144ca72862f31d9777f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.37e-07 | 183 | 183 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.37e-07 | 183 | 183 | 8 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 185 | 183 | 8 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-06 | 186 | 183 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-06 | 186 | 183 | 8 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-06 | 188 | 183 | 8 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 189 | 183 | 8 | 0c612ff5f882f2d8ec744a347780bbbe7cc471bd | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-06 | 189 | 183 | 8 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 189 | 183 | 8 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-06 | 189 | 183 | 8 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 189 | 183 | 8 | bc8949bd4f425ed36e2c05e653c94cb1593c5bee | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-06 | 133 | 183 | 7 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-06 | 192 | 183 | 8 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 1.34e-06 | 192 | 183 | 8 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 193 | 183 | 8 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.40e-06 | 193 | 183 | 8 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-06 | 195 | 183 | 8 | 5dc874641ad9537e4c1369825c1fb0a59f12a83d | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 1.51e-06 | 195 | 183 | 8 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | ASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.51e-06 | 195 | 183 | 8 | 1cdaab17866a1e5170e0f6bfcc69134425fdd8df | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.57e-06 | 196 | 183 | 8 | 7c8aa5853d7096628e35af665097c0299c329753 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.57e-06 | 196 | 183 | 8 | bcd274db4955ea76ca26267a272c7d1929db24f4 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-06 | 196 | 183 | 8 | f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-06 | 196 | 183 | 8 | 80b9139d91dda4de69830d2d443859e047ab5503 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM1|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.57e-06 | 196 | 183 | 8 | ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.62e-06 | 137 | 183 | 7 | 12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 1.63e-06 | 197 | 183 | 8 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-06 | 198 | 183 | 8 | 94e2567f057b2c455a9656b121321a28e7cb1d2b | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.69e-06 | 198 | 183 | 8 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-06 | 198 | 183 | 8 | f3a12a7e23bb4ff6e82fee675dbc090d99587f69 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 199 | 183 | 8 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 199 | 183 | 8 | 97af159fa3a5533ec3d45331fb80c6da8a715aa5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 199 | 183 | 8 | 6783d571d28eac891fcc70380f176b53f35c88ba | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-06 | 199 | 183 | 8 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-06 | 200 | 183 | 8 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-06 | 200 | 183 | 8 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.06e-06 | 142 | 183 | 7 | ed91d2ef4c346f7e1a5402846e2a34cee19c24d1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.84e-06 | 101 | 183 | 6 | 6523c314166dcf66c3ed13c02ca4b886b068e5b8 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 4.35e-06 | 159 | 183 | 7 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-06 | 162 | 183 | 7 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-06 | 162 | 183 | 7 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.98e-06 | 112 | 183 | 6 | 9c3fb470708e76a8f8a3cb9aa17ab130c60fee11 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-06 | 172 | 183 | 7 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-06 | 172 | 183 | 7 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 7.57e-06 | 173 | 183 | 7 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 7.86e-06 | 174 | 183 | 7 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.86e-06 | 174 | 183 | 7 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.86e-06 | 174 | 183 | 7 | 42735f6a8e5ec36dd3d35aceea6d37cf3eaa1871 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.16e-06 | 175 | 183 | 7 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | ASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.47e-06 | 176 | 183 | 7 | b4d280ecc07701d526f50d44c45ea91b3eeb00b1 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.79e-06 | 177 | 183 | 7 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 9.45e-06 | 179 | 183 | 7 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.80e-06 | 180 | 183 | 7 | b94618c1c2592ecf7da3535294aee9243755247a | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 181 | 183 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 182 | 183 | 7 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 182 | 183 | 7 | fea094fe0e7796c084e60b5310c1559658633f7a | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 182 | 183 | 7 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 182 | 183 | 7 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 182 | 183 | 7 | 84f4322ec3d12cb217009f9215af01ebfabc82b4 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 182 | 183 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 183 | 183 | 7 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 183 | 183 | 7 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 183 | 183 | 7 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 183 | 183 | 7 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 184 | 183 | 7 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.17e-05 | 185 | 183 | 7 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.17e-05 | 185 | 183 | 7 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.17e-05 | 185 | 183 | 7 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 186 | 183 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 187 | 183 | 7 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-05 | 187 | 183 | 7 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 187 | 183 | 7 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 1.26e-05 | 187 | 183 | 7 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.30e-05 | 188 | 183 | 7 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-05 | 188 | 183 | 7 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-05 | 188 | 183 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 189 | 183 | 7 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.35e-05 | 189 | 183 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 189 | 183 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-05 | 189 | 183 | 7 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-05 | 190 | 183 | 7 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 190 | 183 | 7 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 190 | 183 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A | CACNA1A DRD2 CYP3A4 PHTF2 GDPD2 FAXDC2 RUNX1T1 ATP8B2 CRHR2 ACAN SLN | 5.09e-07 | 197 | 180 | 11 | 3233_UP |
| Disease | metabolite measurement | PMP22 ATP8B4 CES1 SPPL3 SLC13A3 CHRNA3 ZNF462 NBAS SLC44A5 CD36 SLC22A5 UGT2B10 UGT2B15 ABCC2 TAP1 | 1.39e-06 | 560 | 175 | 15 | EFO_0004725 |
| Disease | depressive disorder (biomarker_via_orthology) | 1.44e-05 | 52 | 175 | 5 | DOID:1596 (biomarker_via_orthology) | |
| Disease | C3 glomerulopathy | 1.68e-05 | 9 | 175 | 3 | C4087273 | |
| Disease | Cocaine Dependence | 2.02e-05 | 139 | 175 | 7 | C0600427 | |
| Disease | Bipolar Disorder | TPO CACNA1A DRD2 HTR5A YWHAH YWHAZ CRHR1 CRHR2 ITPR1 PROKR2 ST8SIA2 CNR2 | 3.02e-05 | 477 | 175 | 12 | C0005586 |
| Disease | X-12007 measurement | 3.50e-05 | 2 | 175 | 2 | EFO_0021276 | |
| Disease | CFHR5 DEFICIENCY | 3.50e-05 | 2 | 175 | 2 | C3553720 | |
| Disease | myocardial infarction (implicated_via_orthology) | 4.62e-05 | 66 | 175 | 5 | DOID:5844 (implicated_via_orthology) | |
| Disease | visual epilepsy (implicated_via_orthology) | 4.82e-05 | 34 | 175 | 4 | DOID:11832 (implicated_via_orthology) | |
| Disease | Alcohol abuse | 4.97e-05 | 67 | 175 | 5 | C0085762 | |
| Disease | hypertension (biomarker_via_orthology) | 6.69e-05 | 227 | 175 | 8 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Cocaine-Related Disorders | 7.25e-05 | 117 | 175 | 6 | C0236736 | |
| Disease | total blood protein measurement | DRD2 SPPL3 PKDCC TMEM176A PHTF2 EBF1 RFX8 YWHAB RMI1 FCGR1BP SOS1 | 8.23e-05 | 449 | 175 | 11 | EFO_0004536 |
| Disease | serum clozapine-to-N-desmethylclozapine ratio measurement | 1.05e-04 | 3 | 175 | 2 | EFO_0600042 | |
| Disease | cerebral cavernous malformation (is_marker_for) | 1.05e-04 | 3 | 175 | 2 | DOID:0060669 (is_marker_for) | |
| Disease | allergic contact dermatitis (is_marker_for) | 1.05e-04 | 3 | 175 | 2 | DOID:3042 (is_marker_for) | |
| Disease | arteriovenous malformations of the brain (is_marker_for) | 1.05e-04 | 3 | 175 | 2 | DOID:0060688 (is_marker_for) | |
| Disease | functional colonic disease (biomarker_via_orthology) | 1.05e-04 | 3 | 175 | 2 | DOID:3877 (biomarker_via_orthology) | |
| Disease | Torsades de Pointes | 1.05e-04 | 3 | 175 | 2 | C0040479 | |
| Disease | Cocaine Abuse | 1.14e-04 | 127 | 175 | 6 | C0009171 | |
| Disease | cannabis dependence | 1.59e-04 | 135 | 175 | 6 | EFO_0007191 | |
| Disease | complement factor H-related protein 4 measurement | 2.06e-04 | 49 | 175 | 4 | EFO_0600091 | |
| Disease | bacterial pneumonia (implicated_via_orthology) | 2.08e-04 | 4 | 175 | 2 | DOID:874 (implicated_via_orthology) | |
| Disease | X-16576 measurement | 2.08e-04 | 4 | 175 | 2 | EFO_0800760 | |
| Disease | serum albumin measurement | CFHR1 TMEM60 TMEM176A EBF1 PKD1L3 YWHAB CHRNA3 RMI1 CD36 EMP1 MAP2K6 SOS1 | 2.31e-04 | 592 | 175 | 12 | EFO_0004535 |
| Disease | Schizophrenia | DRD2 HTR5A CYP3A4 AVPR1A FAM3D OPA1 CHRNA3 MTOR TMEM245 ST8SIA2 TREM1 KDR TAP1 CNR2 GABBR1 | 2.65e-04 | 883 | 175 | 15 | C0036341 |
| Disease | lymphocyte count, response to vaccine | 2.91e-04 | 22 | 175 | 3 | EFO_0004587, EFO_0004645 | |
| Disease | Seizures | 3.38e-04 | 218 | 175 | 7 | C0036572 | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 3.46e-04 | 5 | 175 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | Macrothrombocytopenia | 3.46e-04 | 5 | 175 | 2 | C2751260 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.63e-04 | 102 | 175 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Anhedonia | 3.79e-04 | 24 | 175 | 3 | C0178417 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 4.52e-04 | 107 | 175 | 5 | DOID:6000 (biomarker_via_orthology) | |
| Disease | hereditary spastic paraplegia 31 (implicated_via_orthology) | 5.16e-04 | 6 | 175 | 2 | DOID:0110782 (implicated_via_orthology) | |
| Disease | cortolone glucuronide (1) measurement | 5.16e-04 | 6 | 175 | 2 | EFO_0800552 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 5.16e-04 | 6 | 175 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | migraine with aura (is_implicated_in) | 5.16e-04 | 6 | 175 | 2 | DOID:10024 (is_implicated_in) | |
| Disease | complement factor H-related protein 3 measurement | 5.32e-04 | 169 | 175 | 6 | EFO_0600056 | |
| Disease | vanillylmandelate (VMA) measurement | 7.20e-04 | 7 | 175 | 2 | EFO_0800119 | |
| Disease | X-24574 measurement | 7.20e-04 | 7 | 175 | 2 | EFO_0800897 | |
| Disease | muscular atrophy (implicated_via_orthology) | 7.20e-04 | 7 | 175 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | endometriosis | 7.99e-04 | 252 | 175 | 7 | EFO_0001065 | |
| Disease | Alzheimer's disease (is_marker_for) | 8.96e-04 | 257 | 175 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Hyperkinesia | 8.96e-04 | 32 | 175 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 8.96e-04 | 32 | 175 | 3 | C0751217 | |
| Disease | Huntington's disease (implicated_via_orthology) | 8.96e-04 | 32 | 175 | 3 | DOID:12858 (implicated_via_orthology) | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 9.57e-04 | 8 | 175 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 9.57e-04 | 8 | 175 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | deoxycholic acid glucuronide measurement | 9.57e-04 | 8 | 175 | 2 | EFO_0800575 | |
| Disease | serum N-desmethylclozapine measurement | 9.57e-04 | 8 | 175 | 2 | EFO_0600043 | |
| Disease | Complement deficiency disease | 9.82e-04 | 33 | 175 | 3 | C0272242 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.05e-03 | 75 | 175 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Cardiomyopathies | 1.09e-03 | 130 | 175 | 5 | C0878544 | |
| Disease | brain ischemia (implicated_via_orthology) | 1.17e-03 | 35 | 175 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | premature birth, parental genotype effect measurement | 1.23e-03 | 9 | 175 | 2 | EFO_0003917, EFO_0005939 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.23e-03 | 9 | 175 | 2 | EFO_0600040 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.53e-03 | 10 | 175 | 2 | EFO_0022090 | |
| Disease | Congenital Disorders of Glycosylation | 1.53e-03 | 10 | 175 | 2 | C0282577 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.86e-03 | 11 | 175 | 2 | EFO_0801531 | |
| Disease | response to docetaxel trihydrate, response to antineoplastic agent | 1.86e-03 | 11 | 175 | 2 | GO_0097327, GO_1902519 | |
| Disease | plasma N-desmethylclozapine measurement | 1.86e-03 | 11 | 175 | 2 | EFO_0600039 | |
| Disease | hemopexin measurement | 1.86e-03 | 11 | 175 | 2 | EFO_0008149 | |
| Disease | complement factor H-related protein 5 measurement | 1.99e-03 | 42 | 175 | 3 | EFO_0008098 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.13e-03 | 43 | 175 | 3 | DOID:9261 (is_marker_for) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.22e-03 | 12 | 175 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | hexanoylcarnitine measurement | 2.22e-03 | 12 | 175 | 2 | EFO_0021040 | |
| Disease | Long QT syndrome | 2.22e-03 | 12 | 175 | 2 | cv:C0023976 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 2.22e-03 | 12 | 175 | 2 | DOID:3963 (is_marker_for) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 2.22e-03 | 12 | 175 | 2 | EFO_0800291 | |
| Disease | macular retinal edema (is_marker_for) | 2.22e-03 | 12 | 175 | 2 | DOID:4449 (is_marker_for) | |
| Disease | Anxiety States, Neurotic | 2.27e-03 | 44 | 175 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 2.27e-03 | 44 | 175 | 3 | C1279420 | |
| Disease | Alcohol Use Disorder | 2.27e-03 | 44 | 175 | 3 | C0001956 | |
| Disease | Anxiety Disorders | 2.27e-03 | 44 | 175 | 3 | C0003469 | |
| Disease | asthma (is_implicated_in) | 2.50e-03 | 157 | 175 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.50e-03 | 157 | 175 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | rhinitis (is_marker_for) | 2.58e-03 | 46 | 175 | 3 | DOID:4483 (is_marker_for) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.61e-03 | 13 | 175 | 2 | EFO_0800293 | |
| Disease | Cardiomyopathy, Dilated | 2.92e-03 | 48 | 175 | 3 | C0007193 | |
| Disease | epilepsy (implicated_via_orthology) | 2.94e-03 | 163 | 175 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 3.01e-03 | 100 | 175 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Tobacco Dependence | 3.04e-03 | 14 | 175 | 2 | C0040332 | |
| Disease | X-21470 measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0800817 | |
| Disease | Nicotine Dependence | 3.04e-03 | 14 | 175 | 2 | C0028043 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0800283 | |
| Disease | vascular dementia (biomarker_via_orthology) | 3.04e-03 | 14 | 175 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | Nicotine Use Disorder | 3.04e-03 | 14 | 175 | 2 | C0376384 | |
| Disease | Generalized seizures | 3.12e-03 | 101 | 175 | 4 | C0234533 | |
| Disease | Clonic Seizures | 3.12e-03 | 101 | 175 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 3.12e-03 | 101 | 175 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 3.12e-03 | 101 | 175 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 3.12e-03 | 101 | 175 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 3.12e-03 | 101 | 175 | 4 | C0751123 | |
| Disease | Complex partial seizures | 3.12e-03 | 101 | 175 | 4 | C0149958 | |
| Disease | Single Seizure | 3.12e-03 | 101 | 175 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 3.12e-03 | 101 | 175 | 4 | C3495874 | |
| Disease | Visual seizure | 3.12e-03 | 101 | 175 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 3.12e-03 | 101 | 175 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 3.12e-03 | 101 | 175 | 4 | C0422855 | |
| Disease | Gustatory seizure | 3.12e-03 | 101 | 175 | 4 | C0422854 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSLLWTPQILTISFV | 1 | Q9Y3F1 | |
| WMLFVSELRAATKLT | 11 | Q9NP99 | |
| VAVLTLAILMFLTWL | 6 | Q9GZX9 | |
| LIMQLLRDNLTLWTS | 221 | P61981 | |
| WASLRNLVVSLLNSM | 596 | O00555 | |
| LLISSLVWFMARVII | 46 | Q8WW43 | |
| MWLRAFILATLSASA | 1 | P23141 | |
| STLIMQLLRDNLTLW | 216 | P31946 | |
| LIMQLLRDNLTLWTS | 216 | P27348 | |
| MIWTIILRFAIQDIS | 126 | P12814 | |
| VAMVIDRIFLWVFTL | 471 | P32297 | |
| LIMQLLRDNLTLWTS | 221 | Q04917 | |
| STLIMQLLRDNLTLW | 216 | P31947 | |
| LWRASIVIMLSLNFI | 1106 | Q4VNC1 | |
| WTNLLSRVTLLETEM | 276 | Q9C0F1 | |
| MSLYLTLTIVVTEWR | 421 | Q9NP58 | |
| LLFMASSILTVIVLW | 431 | Q8WXA8 | |
| RTSIDRLMNTLVLWI | 266 | Q8TF62 | |
| LVSRLNVWQARVSSM | 746 | Q96M86 | |
| RTWSLMLVSLIIFIA | 66 | P00846 | |
| SWSLMRLAMVQLVLN | 2486 | Q9Y485 | |
| FSVMLLTTWNIIISL | 996 | Q96F81 | |
| TSIDRLMNTLVLWIF | 286 | P98198 | |
| LVTLGIMWVLSALVS | 151 | P34972 | |
| SFIVLMIISSAWLIF | 201 | Q86XS8 | |
| QTITAWETRMAVRLL | 131 | Q7Z2G1 | |
| LLQQEMVTWRLLASL | 211 | P57740 | |
| ITLQALSEANRRLWM | 346 | O60890 | |
| MNWGINLLISLTFLT | 506 | Q8TD20 | |
| FRWMAQVLASELSLV | 76 | Q2M2E3 | |
| WSLLVTLVVLFIMTG | 271 | Q96EP9 | |
| RTAAWLLTMNAQLLE | 1001 | Q5VWQ8 | |
| GIMFLVNTVLWVTIR | 206 | Q92637 | |
| MRLFLWNAVLTLFVT | 1 | Q9NWM8 | |
| VIMLFVSTIANVWLV | 16 | P54849 | |
| LFTLLGNLLIMATVW | 36 | Q8NGA6 | |
| LFTLLGNLLIMATVW | 36 | O60403 | |
| FARIIMIGTLTALQW | 316 | Q00325 | |
| ALIFAIVTTWMFIRS | 11 | Q96BQ1 | |
| ASMFVSLLILSWIAI | 101 | Q96P67 | |
| LWTAMLISLAIVIAL | 2321 | Q14643 | |
| MISVKRNTWRALSLV | 1 | Q06455 | |
| AVMLIQAAIRSWLTR | 786 | Q96H55 | |
| TLVAEAARMWNLIVL | 251 | Q9UBS5 | |
| ILTELLMVALTVRTW | 1051 | O43861 | |
| FSSKEIITFWQVMLR | 311 | O75752 | |
| DLAMETWLLLAVSLV | 6 | P08684 | |
| MAWALLLLTLLTQDT | 1 | P01705 | |
| TLFALRMATWNQILD | 286 | P43088 | |
| LTLALVWQLMRRYTL | 491 | Q14651 | |
| QTLTLALVWQLMRRY | 491 | P13797 | |
| WRDLRNLVIEMVLST | 316 | P54750 | |
| RVTWISMSLAALLIG | 846 | P07202 | |
| RFIIMVTIWSAVFLN | 66 | P26718 | |
| MWLLVSVILISRISS | 1 | P36980 | |
| TSSSVLWQMRRQLLL | 331 | Q9H0H0 | |
| IHWNLITTFILRNVM | 151 | Q13324 | |
| ITTFILRNVMWFLLQ | 156 | Q13324 | |
| MLWTLLSIVVAFAEL | 11 | Q6ZUX7 | |
| ITNCVSTMLLLWTFL | 496 | Q9HCC8 | |
| STMLLLWTFLLQRRF | 501 | Q9HCC8 | |
| MWLLADIISVLFIVA | 471 | Q6W3E5 | |
| LNITQTLNWLVRMTS | 1246 | Q92887 | |
| LLVLGSVMSVLAIWR | 576 | Q5JZY3 | |
| AVFIVMTQSVLLLWE | 291 | Q86V85 | |
| LLRWTTATTMKVLSN | 1406 | A2RRP1 | |
| MRQTVVTTWVLHLAL | 61 | Q9Y5Y4 | |
| MTTLLWVFVTLRVIT | 1 | P16112 | |
| IFSIFLMAVSWNITL | 31 | Q8NGZ9 | |
| LMAVSWNITLILLIH | 36 | Q8NGZ9 | |
| LATSLMWVLVDVFLL | 11 | Q8IUC8 | |
| DVVLFWRIQRMLAIT | 876 | O60313 | |
| LWIMIALALAVIITS | 311 | O75787 | |
| QLTRSIWTIDLAYLM | 61 | Q96NT3 | |
| SITMWFSLALIITTI | 246 | Q96IV6 | |
| MQFVSWATLLTLLVR | 1 | Q9P2N4 | |
| WATLLTLLVRDLAEM | 6 | Q9P2N4 | |
| MLTLQTWLVQALFIF | 1 | P40189 | |
| KSSMFQVRTLRELLW | 166 | P16671 | |
| TGVQVSSRIFMVWLI | 141 | B0YJ81 | |
| LTSFQVMSRVFLIWA | 106 | Q6Y1H2 | |
| QMLGWILITLATIAA | 186 | Q5JW98 | |
| MIALTWALSAVISLA | 161 | P47898 | |
| LLSASILVLWMLQGS | 16 | Q7Z692 | |
| LQVIFGTMLVWSELI | 291 | Q9UH73 | |
| FILRNATWFVVQLTM | 191 | P34998 | |
| MLLLFSVILISWVST | 1 | Q9BXR6 | |
| MESAITLWQFLLQLL | 1 | P41970 | |
| LRQTWLAFMIILSIL | 311 | Q8IWA5 | |
| LIGLTIAMVLSWIFL | 246 | Q8NCS7 | |
| IAMVLSWIFLILLRF | 251 | Q8NCS7 | |
| RVTVMISIVWVLSFT | 151 | P14416 | |
| MLLWSLLVIFDAVTE | 1 | Q96LA5 | |
| MWLLVSVILISRISS | 1 | Q03591 | |
| WLIILISSLMVTSLT | 471 | Q9BZW2 | |
| VLLLSLAMNTWAQTI | 556 | Q8WWT9 | |
| VLLQGLSLIVTWFML | 101 | O60779 | |
| SFIVLENLMVLIAIW | 51 | Q99500 | |
| ILDLLRTWNIRMVTI | 331 | O76082 | |
| WSRLIHMSIVISVFI | 196 | Q08AI6 | |
| EFLMISNSGLLVIIW | 196 | Q15615 | |
| LLILISFSVVTWMIF | 11 | Q8N323 | |
| LFTLLGNLLIMATVW | 36 | Q9Y4A9 | |
| WSLGITMIELAILRF | 241 | P52564 | |
| TALLGNTLIVTAIWM | 41 | Q8NGK6 | |
| FWVMNTSIQSTIILL | 1041 | P42345 | |
| DQIINWLLEFRSSIM | 86 | Q9NYV6 | |
| RAVMTILLWAQSSLK | 306 | P59533 | |
| LNRTLSKLQWVSVFM | 136 | P78382 | |
| SMVIISFVVRVSLVW | 551 | Q8N3S3 | |
| MVFLTAQLWLRNRVT | 1 | Q9BYC9 | |
| MALSWLQRVELALFA | 1 | Q7Z7N9 | |
| TLEMFLSRILASWTN | 351 | Q6YHU6 | |
| MIQLLQTSWEDRFRI | 241 | Q504Y2 | |
| MTEATFDTLRLWLII | 306 | Q8NDZ6 | |
| SRLLVASWVMQIVLG | 51 | Q96HP8 | |
| ALFRTLQAMLLGVWI | 186 | Q96HP8 | |
| MNVTSIALRAETWLL | 1 | Q9H9A7 | |
| IWSMFTAILRKSVRN | 136 | Q8NFP9 | |
| SWMISIILSVLQNIF | 1186 | Q7Z443 | |
| WNIFDSIIVILSLME | 781 | Q14524 | |
| RSWMLAALTLLVVFL | 6 | Q92186 | |
| NLMSLNSINWSRVLV | 216 | Q86YJ6 | |
| LWGSVSLTMVTLITL | 321 | Q03518 | |
| LFLWMVTRINQQLDT | 436 | P11055 | |
| LAVGANTTLLMTIWL | 41 | Q8NH54 | |
| IAALNSLSQSLMVLW | 151 | O14581 | |
| ILVSTSLDATMRIWA | 231 | Q9H1Z4 | |
| ITDRWILSFMQSLIG | 691 | P41252 | |
| MVSWIISRLVVLIFG | 1 | Q9H902 | |
| NFTIVLITVILMWLL | 11 | O00631 | |
| LITVILMWLLVRSYQ | 16 | O00631 | |
| LLKMIRHTTNLTLWF | 821 | Q07889 | |
| NIFGVILFLRLTWMV | 131 | Q9UP95 | |
| SVLMLNRSLSRLQWA | 156 | P78381 | |
| SRWAVFSILLLALMS | 221 | Q9NP94 | |
| LIMQLLRDNLTLWTS | 216 | P63104 | |
| TIVTVLLLMSLHWFI | 56 | Q9P003 | |
| AQMLSSVSTWLAIIL | 1061 | Q8NB49 | |
| LMLKLSTITWIRFAV | 646 | Q8TBB6 | |
| RVLVTMAVWVASILS | 146 | P46094 | |
| WFRIMSEKITRTLQI | 476 | Q9UPY5 | |
| MRMSLAQRVLLTWLF | 1 | Q9H2L4 | |
| TIIFLASIFQLAMWT | 381 | Q9BSA9 | |
| WDSIIIQASTMIISR | 736 | Q7Z392 | |
| SRGWMLLTTINLLAS | 121 | Q8IZQ1 | |
| MQRISSLIHLSLFWA | 1 | A0JD36 | |
| VETIWDMRNLATIFL | 346 | Q8IUR5 | |
| WASVLMLLSSLVSLA | 101 | Q9BQB6 | |
| MVSWIISRLVVLIFG | 1 | Q9BRK0 | |
| TRLLMLWTTLTGVSL | 281 | Q7RTY0 | |
| WMLQTLAFAVTSLVL | 21 | O94991 | |
| AEWTLIAMVLLSLLT | 551 | Q8IXW5 | |
| ISVQRQMLSSLLVRW | 76 | Q8WZ71 | |
| SFSLSVMLVLIWVLT | 146 | Q8TCT6 | |
| LAAFITVMLARRLVW | 121 | Q9NV64 | |
| TVMLARRLVWALISE | 126 | Q9NV64 | |
| LRWNLLLTAVSKAMT | 401 | Q6ZV50 | |
| MAARTLASALVLTLW | 1 | P0DPE3 | |
| SFLIALVWMVSILIA | 171 | Q8NFJ6 | |
| FDSISRLDQWLTTML | 266 | Q9H115 | |
| DQIINWLLEFRSSIM | 86 | A6NIE6 | |
| RTRRFALMVSLSIWI | 126 | Q8IYL9 | |
| ALMVSLSIWILETIF | 131 | Q8IYL9 | |
| LSIWILETIFNAVML | 136 | Q8IYL9 | |
| SLMARETWEVLLLFL | 156 | Q86X10 | |
| RFVIMLALNIWVTVT | 176 | Q8N755 | |
| WVESIVVLNLSSNML | 426 | Q9Y2C9 | |
| RSRLMIAAAWVLSFV | 166 | P37288 | |
| WLMLLTGRVSLAQFA | 181 | Q6UX98 | |
| VWFIFISLAQTMKTL | 366 | Q96K49 | |
| FLSILESLWIVMSRN | 616 | Q9H330 | |
| ESLWIVMSRNVSLLF | 621 | Q9H330 | |
| RASGVVLTSLQWTLM | 671 | P86452 | |
| LIITWSAVAIVMFDL | 56 | Q13061 | |
| WFSIMNSLVIVLFLS | 301 | Q99805 | |
| MALKWTTVLLIQLSF | 1 | P36537 | |
| LKATVTSIMRWAFLD | 1291 | Q96JM2 | |
| WLSLVILMTGVAFVQ | 141 | Q9Y2D2 | |
| WAMALLITLIVVATL | 616 | Q9H1V8 | |
| TAVIAMFFWLLLVII | 771 | P35968 | |
| SILLFMLVIVWQSVF | 191 | Q8IW00 | |
| SVMNLLLVVLWAFAL | 831 | Q92508 | |
| MSLKWTSVFLLIQLS | 1 | P54855 | |
| VSWNSIFILMILAVL | 261 | Q5BJD5 | |
| DVTWILLRTVNNRTM | 586 | P17948 | |
| MDFWLLIIISSSILT | 406 | Q96MT1 | |
| WLQSVQATMILSIIF | 61 | Q01453 | |
| ARLIWTSNRNVILMA | 1466 | Q9Y4E6 | |
| LLSLMGVLVQWRVTA | 226 | Q66K66 | |
| WLSIINSMVLVFLLV | 236 | O15321 | |
| MTSIRAVFIFLWLQL | 1 | A0A0B4J241 | |
| MASLGQILFWSIISI | 1 | Q7Z7D3 | |
| LMLWASSSIVLVLYR | 276 | Q8NFZ6 | |
| TVRIWNETVSNLTLM | 126 | P32418 | |
| LSLEQSRAQMALWTV | 261 | P17050 |